The Efficacy and Safety of Lcaritin Combined With Bevacizumab and FOLFIRI in Treatment of Liver Metastases From Colorectal Cancer
NCT06269445
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
Icaritin Combined With Bevacizumab and FOLFIRI
Sponsor
Sir Run Run Shaw Hospital